Esperela, Fe A.
HRN: 22-14z76 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2025
CEFTAZIDIME 1GM (VIAL)
03/26/2025
04/01/2025
IVTT
2g
Once A Day
T/C HAP
Waiting Final Action